Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 45

  1. Cat.No. Product Name Information/Activity
  2. BCC7736 Pregnanolone 128-20-1 Pregnanolone chemical structure
  3. BCC4930 Primidone Primidone is an anticonvulsant of the pyrimidinedione class. Primidone chemical structure
  4. BCC7095 SB 205384 GABA<sub>A</sub> receptor modulator; slows current decay SB 205384 chemical structure
  5. BCC2314 Topiramate Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase. Topiramate chemical structure
  6. BCC7115 Tracazolate hydrochloride 1135210-68-2 Tracazolate hydrochloride chemical structure
  7. BCC7466 U 89843A 157013-85-9 U 89843A chemical structure
  8. BCC7465 U 90042 134516-99-7 U 90042 chemical structure
  9. BCC6626 SKF 97541 127729-35-5 SKF 97541 chemical structure
  10. BCC6903 TPMPA 182485-36-5 TPMPA chemical structure
  11. BCC6926 (RS)-AMPA hydrobromide 171259-81-7 (RS)-AMPA hydrobromide chemical structure

Items 441 to 450 of 709 total